8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General

Mitigation of 3.5 GHz Electromagnetic Field-Induced BV2 Microglial Cytotoxicity by Polydeoxyribonucleotide

Bioeffects Seen

Pachhapure S, Mufida A, Wei Q, Choi J-S, Jang B-C · 2025

Share:

PDRN may offer protective effects against 3.5 GHz EMF-induced microglial cell damage by modulating reactive oxygen species and key signaling pathways involved in cell death.

Plain English Summary

Summary written for general audiences

This study investigated whether exposure to 3.5 GHz electromagnetic field (EMF) radiation damages BV2 mouse microglial cells and whether polydeoxyribonucleotide (PDRN), a DNA preparation from salmon sperm, can prevent this damage. The researchers found that 2-hour EMF exposure inhibited cell growth and triggered apoptosis through ROS generation and activation of specific signaling pathways, while PDRN treatment effectively countered these toxic effects by suppressing these mechanisms.

Why This Matters

This in vitro study uses BV2 microglial cells, which are commonly used as a model for neuroinflammation research. The 3.5 GHz frequency is relevant to modern wireless communications, though effects observed in cultured cells may not directly translate to intact biological systems.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Pachhapure S, Mufida A, Wei Q, Choi J-S, Jang B-C (2025). Mitigation of 3.5 GHz Electromagnetic Field-Induced BV2 Microglial Cytotoxicity by Polydeoxyribonucleotide.
Show BibTeX
@article{pachhapure_s_mufida_a_wei_q_choi_j_s_jang_b_c_ce2559,
  author = {Pachhapure S and Mufida A and Wei Q and Choi J-S and Jang B-C},
  title = {Mitigation of 3.5 GHz Electromagnetic Field-Induced BV2 Microglial Cytotoxicity by Polydeoxyribonucleotide},
  year = {2025},
  doi = {10.1101/2025.07.21.25331778},
  
}
DOI: 10.1101/2025.07.21.25331778PubMed: 40699785

Quick Questions About This Study

The study included 360,000 type 2 diabetes cases and 1.8 million control subjects across five different ancestry groups, making it the largest global effort to harmonize diabetes genetic data across diverse populations.
Individuals at the 97.5th percentile of genetic risk scores showed 6-fold increased diabetes risk in Admixed American, East Asian, and European populations, while African and South Asian groups showed at least 3-fold increased risk.
Yes, the multi-ancestry genetic risk scores were associated with development of both microvascular and macrovascular diabetes complications, outperforming all previously reported genetic prediction methods across all ancestry groups.
Ancestry-specific genetic risk scores showed limited prediction power in African, Admixed American, and South Asian populations compared to European and East Asian groups, highlighting the need for multi-ancestry approaches in genetic research.
Forty-one percent of the nearly 2.2 million total participants were from non-European backgrounds, representing the largest effort to date to include diverse ancestries in diabetes genetic risk prediction research.